医学分子生物学杂志 ›› 2024, Vol. 21 ›› Issue (5): 445-451.doi: 10.3870/j.issn.1672-8009.2024.05.009

• 论著 • 上一篇    下一篇

miR-550a-5p 诊断非小细胞肺癌脊柱骨转移的价值 #br#

  

  1. 承德医学院附属医院1脊柱外科,3眼科 河北省承德市, 067000 2围场满族蒙古族自治县医院肿瘤科 河北省承德市, 067000
  • 出版日期:2024-09-30 发布日期:2024-10-25
  • 基金资助:
    2024 年河北省政府资助临床医学优秀人才项目 (No. ZF2024236)

Value of miR-550a-5p in Diagnosis of Spinal Bone Metastasis of Nonsmall Cell Lung Cancer #br#

  1. 1Department of Spine Surgery,3 Department of Ophthalmology, the Affiliated Hospital of Chengde Medical College, Chengde, Hebei, 067000, China 2Department of Oncology, Weichang Manchu and Mongolian Autonomous County Hospital, Chengde, Hebei, 067000, China
  • Online:2024-09-30 Published:2024-10-25

摘要: 目的 探究微小 RNA ( miR) -550a-5p 诊断非小细胞肺癌 ( non-small cell lung cancer, NSCLC)脊柱骨转移的价值, 为临床防治提供参考方法 选取 2019 1 ~ 2023 1 月承德医学院附属医院收治的 62 例存在脊柱骨转移 NSCLC 患者, 44 例无脊柱骨转移 NSCLC 患者, 根据磁共振成像或 CT 检查证实,分别纳入脊柱骨转移组无脊柱骨转移组检测比较两组血清 miR-550a-5p、 肺肿瘤标志物 [癌胚抗原(CEA)、 细胞角蛋白 19 可溶性片段 (CYFRA21-1)、 神经元特异性烯醇化酶 ( NSE)]、 骨代谢标志物 [ Ⅰ型胶原吡啶交联氨基末端肽 ( NTx)、 骨转异性碱性磷酸酶 ( bone alkaline phosphatase, BALP)、 Ⅰ 型胶原羧基末端肽 (type Ⅰ collagen carboxy-terminal cross-linked peptide, ICTP)] 水平, 比较不同临床特征 NSCLC患者血清 miR-550a-5p 水平, 分析 NSCLC 脊柱骨转移分级与血清 miR-550a-5p 水平的相关性, 受试者工作特征曲线 (ROC) 分析血清 miR-550a-5p NSCLC 脊柱骨转移的诊断价值结果 脊柱骨转移组血清 miR- 550a-5p、 CEA、 NSE、 CYFRA21-1、 BALP、 ICTP、 NTx 水平均高于无脊柱骨转移组 ( P< 0. 05); 脊柱骨转移组不同肿瘤直径分化程度、 TNM 分期骨转移数量淋巴结转移骨相关事件伴骨痛症状等临床特征 NSCLC 患者 miR-550a-5p 水平比较, 差异有统计学意义 ( P< 0. 05); 不同骨转移分级 NSCLC 患者血清miR-550a-5p、 NSE、 BALP、 CEA、 ICTP、 CYFRA21-1、 NTx 水平比较差异有统计学意义 ( P< 0. 05), 随骨转移分级增加血清 miR-550a-5p 水平肺肿瘤标志物骨代谢标志物均呈升高趋势。 Spearman 相关性分析显示, 血清 miR-550a-5p 水平与骨转移分级、 CEA、 NSE、 CYFRA21-1、 BALP、 ICTP、 NTx 均呈正相关 ( P < 0. 05); 血清 miR-550a-5p、 肺肿瘤标志物骨代谢标志物联合诊断的 AUC 0. 941 (95 % CI: 0. 878 ~0. 978) (P< 0. 05), 大于肺肿瘤标志物骨代谢标志物联合诊断的 AUC 0. 902 (95 % CI: 0. 829 ~ 0. 951)。 结论miR-550a-5p 应用于 NSCLC 脊柱骨转移诊断的价值较高, 其水平与骨转移分级肺肿瘤标志物骨代谢标志物联系密切, 加入 miR-550a-5p 可提高诊断价值

关键词:

miR-550a-5p, 非小细胞肺癌, 脊柱骨转移, CYFRA21-1, BALP, ROC

Abstract: Objective To explore the value of microRNAs (miR-550a-5p) in the diagnosis ofspinal bone metastases in non-small cell lung cancer (NSCLC), and to provide reference for clinical prevention and treatment. Methods Sixty-two NSCLC patients with the presence of spinal bonemetastasis and 44 NSCLC patients without spinal bone metastasis admitted to the Affiliated Hospital of Chengde Medical College from January 2019 to January 2023 were selected and included in the spinal bone metastasis group and the no spinal bone metastasis group, respectively, based on the confirmation of magnetic resonance imaging or CT examination. Serum miR-550a-5p, lung tumor markers [ carcinoembryonic antigen ( CEA ), cytokeratin-19 soluble fragment ( CYFRA21-1 ), neuron-specific enolase (NSE)], bone metabolism markers [type I collagen pyridine cross-linked amino-terminal peptide (NTx), bone transmutation alkaline phosphatase (BALP), Type I collagen carboxyl terminal peptide (ICTP)] were detected and compared between the two groups. The level of serum miR-550a-5p in NSCLC patients with different clinical characteristics was compared, and the association between the grade of NSCLC spine bone metastasis and the level of serum miR- 550a-5p was analyzed. The diagnostic value of serum miR-550a-5p in NSCLC spine bone metastasiswas analyzed by receiver operating characteristic curve (ROC). Results The levels of serum miR-550a-5p, CEA, NSE, CYFRA21-1, BALP, ICTP and NTx in the spinal bone metastasis groupwere higher than those in the non-spinal bone metastasis group (P < 0. 05). There were statisticallysignificant differences in the level of miR-550a-5p among NSCLC patients in spinal bone metastasis group with different tumor diameter, degree of differentiation, TNM stage, number of bone metastases, lymph node metastases, bone-related events and symptoms of bone pain (P< 0. 05). There weresignificant differences in the level of serum miR-550a-5p, NSE, BALP, CEA, ICTP, CYFRA21-1and NTx among NSCLC patients with different bone metastasis grades (P< 0. 05). The levels of serummiR-550a-5p, lung tumor markers and bone metabolism markers were increased with the increase of bone metastasis grade. Spearman correlation analysis showed that the level of serum miR-550a-5p was positively correlated with bone metastasis grade, and the levels of CEA, NSE, CYFRA21-1, BALP,ICTP and NTx (P< 0. 05). The AUC value of serum miR-550a-5p combined with lung tumor markers and bone metabolic markers was 0. 941 (95 % CI: 0. 878-0. 978) (P < 0. 05), which was higher than that of lung tumor markers combined with bone metabolic markers only [0. 902 (95 % CI:0. 829-0. 951)]. Conclusion miR-550a-5p has a high value in the diagnosis of spinal bone metastasisof NSCLC, and its level is closely related to bone metastasis grade, and level of lung tumor markers,and bone metabolic markers. Application of miR-550a-5p combined with lung tumor markers and bonemetabolic markers can improve the diagnostic value.

Key words:

miR-550a-5p, non-small cell lung cancer, spinal bone metastasis, CYFRA21- 1, BALP, ROC

中图分类号: